Terry, I think there was one study funded by PAACT/NIH, I'm not sure, with 7 patients who had advanced prostate cancer. Early 90's, I think. Data was probably published, I may have something in my files. I'll check.
The TNT data from China was not translated into English. Epstein provided a friend with a 2 page summary. However it is available in Mandarin. A researcher in Phil Thorpes' laboratory is fluent in that language and reviewed the data for Peregrine prior to the acquisition by TCLN. That Peregrine agreed to the acquisition, to me speaks volumes.
Of course to someone who needs a reason to buy the stock based on facts, my conjecture is only...my conjecture.
Maurice, you are, of course, right. By the time all the facts are public the stock will be higher. And there will be plenty of money to be made, if this stuff works, for those who want the facts before they invest. But for someone with your attitude your not buying the stock here baffles me. It seems you are talking out of both sides of your mouth. Just my opinion. |
